Skip to main content
. 2021 Jun 18;39(2):113–121. doi: 10.3857/roj.2021.00213

Table 2.

Summary of toxicities, response rates, and PV patency

Value
SBRT related toxicities
 Acute grade 1 elevated LFTs 2 (17)
 Acute grade 1 nausea 2 (17)
 Acute grade 1 fatigue 2 (17)
 Acute grade 1 esophagitis 1 (8)
 Late toxicities 0 (0)
Best response by RECIST v1.1
 Complete response 1 (8)
 Partial response 5 (42)
 Stable disease 4 (33)
 Progressive disease 2 (17)
PV patency after treatment
 Yes 7 (58)
 No 5 (42)

Values are presented as number of patients (%).

PV, portal vein; SBRT, stereotactic body radiation therapy; LFT, liver function test; RECIST, Response Evaluation Criteria in Solid Tumors.